215 related articles for article (PubMed ID: 21864660)
1. NMR imaging of chitosan and carboxymethyl starch tablets: swelling and hydration of the polyelectrolyte complex.
Wang YJ; Assaad E; Ispas-Szabo P; Mateescu MA; Zhu XX
Int J Pharm; 2011 Oct; 419(1-2):215-21. PubMed ID: 21864660
[TBL] [Abstract][Full Text] [Related]
2. Membrane formation and drug loading effects in high amylose starch tablets studied by NMR imaging.
Thérien-Aubin H; Zhu XX; Ravenelle F; Marchessault RH
Biomacromolecules; 2008 Apr; 9(4):1248-54. PubMed ID: 18357992
[TBL] [Abstract][Full Text] [Related]
3. Imaging of high-amylose starch tablets. 3. Initial diffusion and temperature effects.
Thérien-Aubin H; Baille WE; Zhu XX; Marchessault RH
Biomacromolecules; 2005; 6(6):3367-72. PubMed ID: 16283767
[TBL] [Abstract][Full Text] [Related]
4. Cross-linked high amylose starch derivatives for drug release. II. Swelling properties and mechanistic study.
Mulhbacher J; Ispas-Szabo P; Mateescu MA
Int J Pharm; 2004 Jul; 278(2):231-8. PubMed ID: 15196628
[TBL] [Abstract][Full Text] [Related]
5. The influence of protonation ratio on properties of carboxymethyl starch excipient at various substitution degrees: Structural insights and drug release kinetics.
Assaad E; Mateescu MA
Int J Pharm; 2010 Jul; 394(1-2):75-84. PubMed ID: 20435114
[TBL] [Abstract][Full Text] [Related]
6. Carboxymethyl high amylose starch: Chitosan self-stabilized matrix for probiotic colon delivery.
Calinescu C; Mateescu MA
Eur J Pharm Biopharm; 2008 Oct; 70(2):582-9. PubMed ID: 18602991
[TBL] [Abstract][Full Text] [Related]
7. Carboxymethyl high amylose starch as excipient for controlled drug release: mechanistic study and the influence of degree of substitution.
Lemieux M; Gosselin P; Mateescu MA
Int J Pharm; 2009 Dec; 382(1-2):172-82. PubMed ID: 19716866
[TBL] [Abstract][Full Text] [Related]
8. Mucoadhesive properties of cross-linked high amylose starch derivatives.
Mulhbacher J; Ispas-Szabo P; Ouellet M; Alex S; Mateescu MA
Int J Biol Macromol; 2006 Dec; 40(1):9-14. PubMed ID: 16837041
[TBL] [Abstract][Full Text] [Related]
9. Effect of chitosan coating on the swelling and controlled release of a poorly water-soluble drug from an amphiphilic and pH-sensitive hydrogel.
Colinet I; Dulong V; Mocanu G; Picton L; Le Cerf D
Int J Biol Macromol; 2010 Aug; 47(2):120-5. PubMed ID: 20471413
[TBL] [Abstract][Full Text] [Related]
10. High-amylose carboxymethyl starch matrices for oral sustained drug-release: in vitro and in vivo evaluation.
Nabais T; Brouillet F; Kyriacos S; Mroueh M; Amores da Silva P; Bataille B; Chebli C; Cartilier L
Eur J Pharm Biopharm; 2007 Mar; 65(3):371-8. PubMed ID: 17275270
[TBL] [Abstract][Full Text] [Related]
11. Hydroxypropylated starches of varying amylose contents as sustained release matrices in tablets.
Onofre FO; Wang YJ
Int J Pharm; 2010 Jan; 385(1-2):104-12. PubMed ID: 19879935
[TBL] [Abstract][Full Text] [Related]
12. High-amylose sodium carboxymethyl starch matrices for oral, sustained drug release: development of a spray-drying manufacturing process.
Brouillet F; Baylac G; Cartilier L; Bataille B
Drug Dev Ind Pharm; 2010 Jul; 36(7):795-805. PubMed ID: 20136492
[TBL] [Abstract][Full Text] [Related]
13. Chitosan/starch fibers and their properties for drug controlled release.
Wang Q; Zhang N; Hu X; Yang J; Du Y
Eur J Pharm Biopharm; 2007 Jun; 66(3):398-404. PubMed ID: 17196808
[TBL] [Abstract][Full Text] [Related]
14. Studies of chitosan/Kollicoat SR 30D film-coated tablets for colonic drug delivery.
Fan LF; He W; Chang YZ; Xiang B; Du Q; Wang F; Qin M; Cao DY
Int J Pharm; 2009 Jun; 375(1-2):8-15. PubMed ID: 19457627
[TBL] [Abstract][Full Text] [Related]
15. Carboxymethyl starch: Chitosan monolithic matrices containing diamine oxidase and catalase for intestinal delivery.
Calinescu C; Mondovi B; Federico R; Ispas-Szabo P; Mateescu MA
Int J Pharm; 2012 May; 428(1-2):48-56. PubMed ID: 22402476
[TBL] [Abstract][Full Text] [Related]
16. A new approach combining different MRI methods to provide detailed view on swelling dynamics of xanthan tablets influencing drug release at different pH and ionic strength.
Mikac U; Sepe A; Kristl J; Baumgartner S
J Control Release; 2010 Aug; 145(3):247-56. PubMed ID: 20417675
[TBL] [Abstract][Full Text] [Related]
17. Carboxymethyl starch and lecithin complex as matrix for targeted drug delivery: I. Monolithic mesalamine forms for colon delivery.
Mihaela Friciu M; Canh Le T; Ispas-Szabo P; Mateescu MA
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):521-30. PubMed ID: 23562535
[TBL] [Abstract][Full Text] [Related]
18. High-amylose sodium carboxymethyl starch matrices for oral, sustained drug-release: formulation aspects and in vitro drug-release evaluation.
Brouillet F; Bataille B; Cartilier L
Int J Pharm; 2008 May; 356(1-2):52-60. PubMed ID: 18280069
[TBL] [Abstract][Full Text] [Related]
19. Effect of binder additives on terbutaline hydrogels of alpha-PVA/NaCl/H(2)O system in drug delivery: I. Effect of gelatin and soluble starch.
Shaheen SM; Takezoe K; Yamaura K
Biomed Mater Eng; 2004; 14(4):371-82. PubMed ID: 15472386
[TBL] [Abstract][Full Text] [Related]
20. RETRACTED: Evaluation of amorphous debranched starch as extended-release matrices in tablets.
Liu G; Hong Y; Gu Z
Carbohydr Polym; 2013 Oct; 98(1):995-1001. PubMed ID: 23987439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
